Delivery Order SPE2DB25D3108-SPE2DB25FPDYV
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $6,419.43 and an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $1,555.93. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by May 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 at a contract value of $3,641.99. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10mg tablets in a quantity of 100 units, with a contract ceiling value of $3,111.86. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $4,491.92. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion on August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $3,111.86. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is September 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.34 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $2,190.50. This firm fixed-price delivery order, which is not set-aside designated, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2025. The contract represents a continuation of AmerisourceBergen's ongoing...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10 mg tablets in a quantity of 100 units, with a ceiling value of $7,124.30. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 100 tablets of Clobazam 10 mg at a ceiling value of $6,303.15. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDYVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. This delivery order represents a single transaction with a firm fixed price ceiling value of $3,111.86 and an ultimate completion date of September 18, 2025. The award was made through open competition with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a maximum value of $999.99 million and extends through December 2026. As a prime vendor for pharmaceutical supply, AmerisourceBergen Drug Corp provides a comprehensive range of medications and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The Clobazam order fulfills military pharmaceutical requirements, with the drug serving as an anticonvulsant medication for neurological treatment needs within the federal health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/17/25 |